¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø ¾î¶² Ä¡·á¸¦?

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø, #ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿øÇÑÀÇ¿ø, #¸¸¼ºµÎµå·¯±âÄ¡·á, #ÀÎõ¸¸¼ºµÎµå·¯±âÄ¡·á, #¸¸¼ºµÎµå·¯±âÇÑÀÇ¿øÇÑÀÇ¿ø, #¸¸¼ºµÎµå·¯±âÄ¡·áÇÑÀÇ¿ø, #ÀÎõ¸¸¼ºµÎµå·¯±âÄ¡·á, #¿¬¼ö±¸¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø,,ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿øÇÑÀÇ¿ø,,¸¸¼ºµÎµå·¯±âÄ¡·á,,ÀÎõ¸¸¼ºµÎµå·¯±âÄ¡·á,,¸¸¼ºµÎµå·¯±âÇÑÀÇ¿øÇÑÀÇ¿ø,,¸¸¼ºµÎµå·¯±âÄ¡·áÇÑÀÇ¿ø,,ÀÎõ¸¸¼ºµÎµå·¯±âÄ¡·á,,¿¬¼ö±¸¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø ¾È³çÇϼ¼¿ä. ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø ¿¬¼ö±¸ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø ¿¬¼ö±¸ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¸¸¼ºµÎµå·¯±âÄ¡·á, µÎµå·¯±âÇÑÀÇ¿ø, ¾Ë·¯ÁöµÎµå·¯±â, ÇǺεε巯±â, ÇǺ馱âÁõ, ÇÞºûµÎµå·¯±â, Àӽŵε巯±â, µÎµå·¯±â°¡·Á¿ò, ¾Æ±â¾ó±¼µÎµå·¯±â, ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø, µÎµå·¯±âÁõ»ó, °¡½¿µÎµå·¯±â, ¿øÀθ𸦵ε巯±â, ¸¸¼ºµÎµå·¯±â, ¿©¸§Ã¶µÎµå·¯±â, µÎµå·¯±â¿¬°í, ±¸Áø¼ºµÎµå·¯±â, ½ÄÁßµ¶µÎµå·¯±â, ¾ÆÀ̵ε巯±â, Ãâ»êÈĵε巯±â, ¾Ë·¹¸£±âµÎµå·¯±â, µÎµå·¯±â, Äݸ°¼ºµÎµå·¯±â, ¾Æµ¿µÎµå·¯±â, µÎµå·¹±âµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ´Ü¼ø±³Á¤Ãß³ª, Çâ±â±¤¼±¿ä¹ý, ¿µ¾ç±³À°, º¹Àâ¿îµ¿Ä¡·á, ½½¸µ¿îµ¿, manipulation, aroma therapy, µÎ°³°æÃßÃß³ª, ¹è³óÄ¡·á, Çâ±âÀÚ°¡¿ä¹ý, MSAT, acuatic therapy, ¹Ì¼¼´Ù·ûÀڱؿä¹ý, ÂÁö¾Ê´Âħġ·á, ÅÙ½º, »öä¿ä¹ý, ¸Æ¹Ý¼®¿Â½ÀÂòÁú±â, ȣħ, Àü±âÀÚ±ØÄ¡·á, ÇѹæÅëÀü¾à¹°¿ä¹ý, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀ̸ç ÀÎõ ¿¬¼ö±¸ µ¿Ãá3µ¿, ºÎ»ê ¼­±¸ ¾Ï³²µ¿, °æ±â ¾È¼º½Ã ¿ø°î¸é, Àü³² º¸¼º±º ¹®´ö¸é, ÃæºÏ Á¦Ãµ½Ã Á¦Ãµ¿ìü±¹»ç¼­ÇÔ, Á¦ÁÖ Á¦Áֽà ÀϵµÀϵ¿, ¿ï»ê ³²±¸ ¿ëÀᵿ, ÀüºÏ ÀÍ»ê½Ã ¸ðÇöµ¿2°¡, °æ³² ÇÕõ±º À²°î¸é, °æºÏ °æÁֽà º¸¹®µ¿, Àü³² ¿Ïµµ±º ±Ý´ç¸é, °æ³² Å뿵½Ã ¹«Àüµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ´ë¿Üµ¿, °æ±â È­¼º½Ã ¼öÈ­µ¿, °æ±â È­¼º½Ã ¼öÈ­µ¿, Ãæ³² ¼­Ãµ±º ½ÃÃʸé, ÀüºÏ ³²¿ø½Ã ¾Æ¿µ¸é, ºÎ»ê »çÇϱ¸ ½ÅÆòµ¿, °æºÏ ºÀÈ­±º ¹ýÀü¸é, °æºÏ ¿µÃµ½Ã Á¶±³µ¿, °æ±â ¼º³²½Ã ¼öÁ¤±¸ ¼º³²¿ìü±¹»ç¼­ÇÔ, °æºÏ Æ÷Ç׽à ³²±¸ Àå±â¸é, °æ±â ½ÃÈï½Ã ´ë¾ßµ¿, ¿ï»ê ³²±¸ ¾ßÀ½µ¿, °­¿ø Æòⱺ ¹Ìź¸é, Àü³² ¸ñÆ÷½Ã Á×±³µ¿, °æ³² Å뿵½Ã ¸íÁ¤µ¿, °æºÏ ¿µÃµ½Ã ä½Åµ¿, °æ±â ¼º³²½Ã ¼öÁ¤±¸ ¾çÁöµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ Áß¼ºµ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿øÄ¡·á ãÀ¸½Ã´Â °Ë´Ü, ÆÈź¸é, ¹®Çе¿, ¼®³²µ¿, ¸¶µµ¸é, ¼Û¸²µ¿, ºÎõ, °è»êµ¿, ¿ëÀ¯µµ, °¡Á¤µ¿, ¿Á·Ãµ¿, Á־ȵ¿, ÀÎõÁÖ¾È, Á¤¿Õµ¿, ¸¸¼öµ¿, »óµ¿, ºñºÀ¸é, ¿¬¼öµ¿, ¿µÁ¾Çϴõµ½Ã, ±¸¿ùµ¿, Á־ȿª, ¼Ò·¡Æ÷±¸, ¼±Çе¿, µ¿±¸, û¶ó, °Ë¾Ï, ¿µÁ¾µµ, ³²±¸, ½ÃÈ­, ¿î¼­µ¿, ÇÐÀ͵¿, ´ëºÎµµ, °£¼®µ¿, ºÀ´ãÀ¾, µµ¸²µ¿ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Ruzicka T, Hanifin JM, Furue M, et al. Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis. N Engl J Med 2017; 376:826. 2. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014; 70:338. 3. Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol 2008; 159:245. 4. Ahmed A, Solman L, Williams HC. Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal. Br J Dermatol 2018; 178:659. 5. Bae JM, Choi YY, Park CO, et al. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol 2013; 132:110. 6. Stein Gold LF, Eichenfield LF. Nonpharmacologic strategies and topical agents for treating atopic dermatitis: an update. Semin Cutan Med Surg 2017; 36:S42. 7. Beck LA, Thaçi D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 2014; 371:130. 8. Xu S, Immaneni S, Hazen GB, et al. Cost-effectiveness of Prophylactic Moisturization for Atopic Dermatitis. JAMA Pediatr 2017; 171:e163909.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ¸¸¼ºµÎµå·¯±âÇÑÀÇ¿ø ¾î¶² Ä¡·á¸¦?""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõ±¸¾È¿Í»ç ÇÑÀÇ¿ø ȸº¹À§ÇØ
´ÙÀ½±Û ÀÎõ°Ç¼±ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¾îµð·Î °¥±î?
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
812 ¾ÆÀÌÁ¶¾Æ 2¿ù ¼³ À̺¥Æ® ¾È³» 0 1,325 2021-02-01
811 ÀÌÈñ¼ºÇÑÀÇ¿ø ¼³³¯ ¼±¹°¼¼Æ® °æ¿Á°í, °øÁø´Ü ÇÒÀÎ À̺¥Æ® 0 4,690 2021-02-01
810 [¹Ý¿ù´çÇÑÀÇ¿ø] "¾Æ¸§´Ù¿òÀÇ ¹ýÄ¢" ¶óÀ²ÇÑÀÇ¿ø 2¿ù EVENT 0 1,291 2021-02-01
809 õ¾ÈÁ¡ ¼û½¬´ÂÇÑÀÇ¿ø 2¿ù Áø·áÀÏÁ¤&¼³³¯À̺¥Æ®¾È³»µå¸³´Ï´Ù 0 972 2021-02-01
808 Ç㵿¼®ÇÑÀÇ¿ø ¼³ ¼±¹°¿ë Ưº°ÇÒÀÎ À̺¥Æ® 0 1,047 2021-01-18
807 °í¿î¼±ÇüÇÑÀÇ¿ø ¼³¸ÂÀÌ ¹î»ìȯ Ãß°¡ÁõÁ¤ À̺¥Æ® 0 1,238 2021-01-18
806 â¿ø ÀÇⱸ µµ°èµ¿ ¿­¸°ÇÑÀÇ¿ø ¼³³¯ À̺¥Æ® 0 1,976 2021-01-18
805 [»ý±âÇÑÀÇ¿ø 1¿ù EVENT!] 2021³â ¿Ô¼Ò! ¶È¶È~¾îµðÀÖ¼Ò EVENT 0 940 2021-01-15
804 ÀϸÆÇÑÀÇ¿ø ºÎ»êÁ¡ 1¿ù ´ÙÀ̾îÆ® À̺¥Æ® ÇýÅþȳ» 0 1,145 2021-01-15
803 ´ëÀüÇѹ溴¿ø ²Éºû 1¿ù ÇÒÀÎÀ̺¥Æ® 0 2,561 2021-01-11
802 ¼º´©°¡º´¿ø ½Å³â¸ÂÀÌ 1¿ù Çѹæ°ú À̺¥Æ® 0 1,459 2021-01-11
801 Âù´©¸®Çѹ溴¿ø ºäƼŬ¸®´Ð 1¿ù~2¿ù À̺¥Æ® ½ÃÇàÇÕ´Ï´Ù 0 2,022 2021-01-11
800 ±èÇØÁ¦ÁßÇÑÀÇ¿ø 2021 ¼³¸ÂÀÌ °øÁø´Ü, °æ¿Á°í, Á¦Áßȯ À̺¥Æ® 0 1,970 2021-01-11
799 ÇÏ´ÃüÇÑÀÇ¿ø ¾È»ê¿©µå¸§ÈäÅÍ À̺¥Æ® 0 1,915 2021-01-07
798 ÀºÇ೪¹«ÇÑÀÇ¿ø 2021³â »õÇØ À̺¥Æ® 0 1,132 2021-01-07
797 û´ãBSÇÑÀÇ¿ø 2021³â 1¿ù~3¿ù ÇÁ·Î±×·¥ À̺¥Æ®¾È³» 0 1,357 2021-01-07
796 À±½½ÇÑÀÇ¿ø 1ÁÖ³â À̺¥Æ® 0 1,354 2021-01-07
795 ¼ö·ÁÇÑÀÇ¿ø 2021 »õÇؼҸÁ À̺¥Æ® 1 1,297 2021-01-04
794 °­³²´ÙÀ̾îÆ® Àü¹® ¼±ÀÌ°íÀº ÇÑÀÇ¿ø ¼öÇè»ý À̺¥Æ® 0 1,293 2021-01-04
793 Ç⸲´çÇÑÀÇ¿ø 1¿ù ÇÁ·Î¸ð¼Ç ¾È³» 0 1,584 2021-01-04
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷